PulmonX's Series C Round

PulmonX raised a round of funding on February 12, 2010.

PulmonX is engaged in the design, development and manufacture of products to deliver effective endoscopic lung volume reduction (ELVR) to patients with emphysema-induced hyperinflation. ELVR involves …

Articles about PulmonX's Series C Round: